ATE180788T1 - Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide - Google Patents

Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide

Info

Publication number
ATE180788T1
ATE180788T1 AT91918401T AT91918401T ATE180788T1 AT E180788 T1 ATE180788 T1 AT E180788T1 AT 91918401 T AT91918401 T AT 91918401T AT 91918401 T AT91918401 T AT 91918401T AT E180788 T1 ATE180788 T1 AT E180788T1
Authority
AT
Austria
Prior art keywords
polypeptides
dopaminergic receptor
receptor
nucleic acid
acid sequences
Prior art date
Application number
AT91918401T
Other languages
English (en)
Inventor
Bruno Giros
Pierre Sokoloff
Jean-Charles Schwartz
Marie-Pascale Martres
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE180788T1 publication Critical patent/ATE180788T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT91918401T 1990-11-06 1991-10-16 Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide ATE180788T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9013731A FR2668771B1 (fr) 1990-11-06 1990-11-06 Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.

Publications (1)

Publication Number Publication Date
ATE180788T1 true ATE180788T1 (de) 1999-06-15

Family

ID=9401888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918401T ATE180788T1 (de) 1990-11-06 1991-10-16 Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide

Country Status (9)

Country Link
EP (1) EP0507908B1 (de)
JP (1) JPH05503219A (de)
AT (1) ATE180788T1 (de)
AU (1) AU8857991A (de)
CA (1) CA2072874C (de)
DE (1) DE69131289T2 (de)
ES (1) ES2134781T3 (de)
FR (1) FR2668771B1 (de)
WO (1) WO1992007937A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE19600934A1 (de) 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
US20010053849A1 (en) * 1999-06-16 2001-12-20 Mary Jeanne Kreek Plural biological sample arrays, and preparation and uses thereof
EP1683790A1 (de) 2005-01-24 2006-07-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) 3,4-Dihydro-2-Naphthamidderivate als selektive Dopamin-D3-Liganden

Also Published As

Publication number Publication date
CA2072874A1 (fr) 1992-05-07
FR2668771B1 (fr) 1995-03-17
DE69131289D1 (de) 1999-07-08
JPH05503219A (ja) 1993-06-03
DE69131289T2 (de) 1999-12-16
ES2134781T3 (es) 1999-10-16
AU8857991A (en) 1992-05-26
EP0507908A1 (de) 1992-10-14
EP0507908B1 (de) 1999-06-02
CA2072874C (fr) 2004-12-28
FR2668771A1 (fr) 1992-05-07
WO1992007937A1 (fr) 1992-05-14

Similar Documents

Publication Publication Date Title
PT100122A (pt) Polipeptidos correspondentes aos locais de ligacao induzidos no receptor (ribs), anticorpos anti-ribs e processos de deteccao e de isolamento do anticorpo
HK1006854A1 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
LU88344I2 (fr) Octreotide
ATE87655T1 (de) Markierer der t-zelle aktivierung.
DE69334100D1 (de) Elk ligand, ein cytokin
DE69230525D1 (de) Technetium-99m markierte Polypeptide zur Bildformung
ES8607564A1 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
YU79491A (sh) Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina
HK1013844A1 (en) T cell receptor-specific for antigen polypeptides and related polynucleotides
EP0512064A4 (en) Extracellular segments of human -g(e) immunoglobulin anchoring peptides and antibodies specific therefor
DE68925199D1 (de) Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke
ATE180788T1 (de) Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide
DE69121861D1 (de) Peptide von sm-d-antigen, deren benützung zum nachweis von disseminierten lupus-erythemateux
DE69033260D1 (de) Intrazelluläres Antigen in einer Subpopulation von CD8+T-Lymphozyten und ein monoklonaler Antikörper spezifisch dafür
DE3881275D1 (de) Monoklonaler antikoerper zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten.
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
Rock et al. Variant Forms of Factor VIII Procoagulant-Like Material in Haemophiliacs
Novak T cell repertoire to the synthetic polypeptide antigen poly-18

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties